Kopran Limited — Press Release
KopranKopran Limited has informed the Exchange regarding a press release dated October 22, 2026, titled " Closure of Medicine Authority European Union (EU)- conducted GMP inspection at the Company s Formulation manufacturing facility located at Khopoli. ".
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Kopran (KOPRAN).
- Category: Company.
Why it matters
A routine update for Kopran. Use the price and stock snapshot to gauge how the market is responding.








